Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
08.01.26
/
50%
€160.80
Target price
08.01.27
-
Performance (%)
-5.49%
Price
15:13
€151.98
Summary
This prediction is currently active. With a performance of -5.49%, the BUY prediction for Biogen Inc. by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 08.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.791% | -0.791% |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat